|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 07-16 | French and Benelux stocks-Factors to watch on July 16 | RE |
| 07-16 | Medincell Obtains EUR28 Million Loans, Plans EUR20 Million Debt Repayment | MT |
Company Valuation: MedinCell
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 287.6 | 186.4 | 246.2 | 275.7 | 476.2 | 911.2 | - | - |
| Change | - | -35.19% | 32.11% | 11.97% | 72.7% | 91.38% | - | - |
| Enterprise Value (EV) 1 | 287.6 | 209.3 | 294.4 | 318.1 | 468.9 | 794 | 896.4 | 880.7 |
| Change | - | -27.23% | 40.69% | 8.03% | 47.42% | 69.34% | 0.13% | -1.75% |
| P/E | -13.6x | -7.42x | -7.72x | -10.9x | -23.2x | -60x | 476x | 49.4x |
| PBR | - | -13.9x | -5.86x | -6.68x | -26.1x | 40.6x | 61.9x | 11.3x |
| PEG | - | -0.5x | -0.3x | 0.4x | 0.8x | 1.9x | -4x | 0x |
| Capitalization / Revenue | 35.1x | 45.6x | 24.9x | 30.5x | 18.7x | 33.3x | 20.4x | 14.2x |
| EV / Revenue | 35.1x | 51.2x | 29.8x | 35.2x | 18.4x | 32.7x | 20x | 13.8x |
| EV / EBITDA | - | -9.39x | -13.2x | -16.5x | -53x | -12,613x | 130x | 36.7x |
| EV / EBIT | -18.7x | -8.79x | -12.3x | -15.2x | -43.6x | -38.3x | 294x | 28.4x |
| EV / FCF | - | -9.1x | -13.4x | -24.3x | 26.3x | -37.9x | -161x | 63.8x |
| FCF Yield | - | -11% | -7.48% | -4.12% | 3.8% | -2.64% | -0.62% | 1.57% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.86 | -1 | -1.27 | -0.88 | -0.62 | -0.4227 | 0.0533 | 0.514 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8.186 | 4.091 | 9.889 | 9.032 | 25.42 | 24.28 | 44.78 | 63.98 |
| EBITDA 1 | - | -22.3 | -22.36 | -19.26 | -8.85 | -0.071 | 6.875 | 24.01 |
| EBIT 1 | -15.37 | -23.81 | -24.02 | -20.94 | -10.76 | -20.74 | 3.052 | 31.06 |
| Net income 1 | -19.02 | -24.81 | -29.5 | -25.04 | -18.44 | -31.29 | 0.7857 | 19.17 |
| Net Debt 1 | - | 22.87 | 48.18 | 42.34 | -7.296 | -15.29 | -14.87 | -30.53 |
| Reference price 2 | 11.70 | 7.42 | 9.81 | 9.59 | 14.40 | 25.38 | 25.38 | 25.38 |
| Nbr of stocks (in thousands) | 24,581 | 25,121 | 25,101 | 28,749 | 33,066 | 35,904 | - | - |
| Announcement Date | 6/16/21 | 6/14/22 | 6/26/23 | 6/10/24 | 6/17/25 | 6/16/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.04x | 12.53x | 26.21x | 0.57% | 1,051B | |
| 27.19x | 6.2x | 16.98x | 2.12% | 609B | |
| 33.15x | 7.52x | 15.43x | 2.7% | 450B | |
| 17.85x | 4.43x | 10.91x | 3% | 330B | |
| 21.66x | 5.55x | 13.44x | 2.84% | 284B | |
| 21.16x | 4.46x | 12.34x | 1.97% | 263B | |
| 14.44x | 5.41x | 11.14x | 3.44% | 223B | |
| 24.02x | 6.35x | 11.22x | 2.75% | 198B | |
| -48.37x | 5.78x | 31.95x | 2.42% | 167B | |
| Average | 16.24x | 6.47x | 16.62x | 2.42% | 397.23B | |
| Weighted average by Cap. | 24.01x | 7.82x | 18.33x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEDCL Stock
- Stock
- Valuation MedinCell
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
